Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Patients with Intestinal Metaplasia in the Lesser Curvature of the Gastric Corpus Require OLGIM Staging: a Secondary Analysis of a Prospective Cohort

NCT06585553 is registered in ClinicalTrials.gov with Shandong University as lead sponsor.

NCT NCT06585553
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06585553 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Patients with Intestinal Metaplasia in the Lesser Curvature of the Gastric Corpus Require OLGIM Staging: a Secondary Analysis of a Prospective Cohort
Lead sponsor
Shandong University
Phase
Observational
Overall status
Completed
Start date
July 1, 2022
Completion date
August 25, 2024
Enrollment
2,121 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

intestinal metaplasia